Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim.
To LB, Bashford J, Durrant S, MacMillan J, Schwarer AP, Prince HM, Gibson J, Lewis I, Swart B, Marty J, Rawling T, Ashman L, Charles S, Cohen B. To LB, et al. Among authors: cohen b. Bone Marrow Transplant. 2003 Mar;31(5):371-8. doi: 10.1038/sj.bmt.1703860. Bone Marrow Transplant. 2003. PMID: 12634728 Clinical Trial.
Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.
Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG. Basser RL, et al. Among authors: cohen b. Blood. 1997 May 1;89(9):3118-28. Blood. 1997. PMID: 9129014 Free article. Clinical Trial.
Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation.
O'Malley CJ, Rasko JE, Basser RL, McGrath KM, Cebon J, Grigg AP, Hopkins W, Cohen B, O'Byrne J, Green MD, Fox RM, Berndt MC, Begley CG. O'Malley CJ, et al. Among authors: cohen b. Blood. 1996 Nov 1;88(9):3288-98. Blood. 1996. PMID: 8896392 Free article. Clinical Trial.
Comparison of the lethal triad and the lethal diamond in severe trauma patients: a multicenter cohort.
Dupuy C, Martinez T, Duranteau O, Gauss T, Kapandji N, Pasqueron J, Holleville M, Abi Abdallah G, Harrois A, Ramonda V, Huet-Garrigue D, Doublet T, Leone M, Legros V, Pottecher J, Audibert G, Millot I, Popoff B, Cohen B, Vardon-Bounes F, Willig M, Gosset P, Angles E, Mellati N, Higel N, Boutonnet M, Pasquier P; and the TraumaBase Group®. Dupuy C, et al. Among authors: cohen b. World J Emerg Surg. 2025 Jan 7;20(1):2. doi: 10.1186/s13017-024-00572-5. World J Emerg Surg. 2025. PMID: 39773274
Infrared nanosensors of piconewton to micronewton forces.
Fardian-Melamed N, Skripka A, Ursprung B, Lee C, Darlington TP, Teitelboim A, Qi X, Wang M, Gerton JM, Cohen BE, Chan EM, Schuck PJ. Fardian-Melamed N, et al. Among authors: cohen be. Nature. 2025 Jan;637(8044):70-75. doi: 10.1038/s41586-024-08221-2. Epub 2025 Jan 1. Nature. 2025. PMID: 39743607
4,283 results